7 Related NICE guidance
-
Tocilizumab for the treatment of rheumatoid arthritis. NICE technology appraisal guidance 198 (2010). [Replaced by NICE technology appraisal guidance 247]
-
Certolizumab pegol for the treatment of rheumatoid arthritis. NICE technology appraisal guidance 186 (2010).
-
Rheumatoid arthritis: the management of rheumatoid arthritis in adults. NICE clinical guideline 79 (2009).
-
Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis.NICE technology appraisal guidance 130 (2007).
-
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs. NICE technology appraisal 225 (2011).